199 posters,  6 sessions,  6 topics,  786 authors,  71 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

131 - 02-25
Comparison of Complications and Length of Hospital Stay in Patients Greater Than 75 That Underwent Radical Cystectomy: A Multi-Institution Analysis

Primary tabs

Rate

No votes yet

Statistics

869 reads

Comparison of Complications and Length of Hospital Stay in Patients Greater Than 75 That Underwent Radical Cystectomy: A Multi-Institution Analysis

Jeremy M. West, B.S., Darshan P. Patel B.S., EviComploj, M.D., Armin Pycha, M.D, William Lowrance, M.D., Robert Stephenson, M.D., Christopher B. Dechet, M.D

University of Utah and Huntsman Cancer Institute, Salt Lake City, UT

Central Hospital of Bolzano, Bolzano, Italy  

Background

Radical cystectomy is the standard treatment for muscle invasive bladder cancer. Elderly patients undergoing this procedure often develop greater morbidity and higher mortality than younger patients. Overall complications in this age group range from 24% to 60.9%. The most commonly reported complications include ileus, pyelonephritis, and urinary diversion related complications. The length of hospital stay varies greatly from institution to institution

Objectives

Evaluate a large series of elderly (≥75 years old) patients undergoing radical cystectomy at two tertiary institutions and compare complications and length of stay. We hypothesize that a greater length of stay is not associated with increased rates of complications in elderly patients undergoing radical cystectomy

Methods

Data was gathered from 212 patients at two tertiary institutions. BMI, co-morbidity, hospital length of stay, complications, and overall mortality were assessed. Complications were categorized using the Clavien-Dindo Classification system
 

Conclusions

Median hospital length of stay was significantly different between two major tertiary institutions. Longer length of stay for elderly patients undergoing radical cystectomy has no effect on the rate of ≥ Grade III complications, 30 day and 90 day mortality, and overall survival